Pacific Biosciences of California Inc (NAS:PACB)
$ 1.645 -0.025 (-1.5%) Market Cap: 448.02 Mil Enterprise Value: 817.48 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 58/100

Q4 2021 Pacific Biosciences of California Inc Earnings Call Transcript

Feb 15, 2022 / 09:30PM GMT
Release Date Price: $11.38 (+3.64%)
Operator

Good day, and thank you for standing by. Welcome to the Pacific Biosciences of California, Inc. Fourth Quarter 2021 Earnings Conference Call. (Operator Instructions) Please be advised that this call is being recorded. (Operator Instructions)

I would now like to hand the conference over to your host today, Todd Friedman, Director of Investor Relations. Please go ahead.

Todd Friedman
Pacific Biosciences of California, Inc. - Director of IR

Good afternoon, and welcome to PacBio's Fourth Quarter and Full Year 2021 Earnings Conference Call.

Earlier today, we issued a press release outlining the financial results we will be discussing on today's call, a copy of which is available in the Investors section of our website at www.pacb.com, or is furnished on Form 8-K available on the Securities and Exchange Commission website at www.sec.gov.

With me today are Christian Henry, President and Chief Executive Officer; Susan

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot